| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Diabetes type 1 | 1,385 | 41 | |
| Diabetes type 2 | 182 | 37 | |
| Cystic fibrosis-related diabetes | 9 | 2 | |
| Elevated blood sugar (hyperglycemia) | 5 | 1 | |
| Latent autoimmune diabetes | 3 | 1 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Low blood sugar (hypoglycemia) | 15 | |
| Weight gain | 6 | |
| Injection site pain | 2 | |
| Reactive hypoglycemia | 2 | |
| Chronic hyperglycemia | 1 | |
| Chronic kidney disease | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 9 | |
| Mild | 23 | |
| None | 48 |
Member evaluations
rotdog62
evaluated on Oct 15, 2013
- Perceived effectiveness for diabetes type 2: Slight
- Side effects: None
betesgirl12
evaluated on Feb 28, 2012
- Perceived effectiveness for diabetes type 1: Major
- Side effects: Mild
Ern
evaluated on Sep 29, 2011
- Perceived effectiveness for diabetes type 1: Major
- Side effects: Moderate